Literature DB >> 16189122

AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters.

Xian-Zhong Su1, Jing Chen, Tohru Mizushima, Teruo Kuroda, Tomofusa Tsuchiya.   

Abstract

We cloned a gene, abeM, for a multidrug efflux pump from Acinetobacter baumannii using Escherichia coli as the host. Sequence analysis revealed that AbeM is a member of the MATE family of pumps. AbeM was found to be an H(+)-coupled multidrug efflux pump and a unique member of the MATE family.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189122      PMCID: PMC1251516          DOI: 10.1128/AAC.49.10.4362-4364.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454.

Authors:  S Magnet; P Courvalin; T Lambert
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

2.  Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii.

Authors:  J Vila; J Ruiz; P Goñi; T Jimenez de Anta
Journal:  J Antimicrob Chemother       Date:  1997-06       Impact factor: 5.790

3.  VmrA, a member of a novel class of Na(+)-coupled multidrug efflux pumps from Vibrio parahaemolyticus.

Authors:  Jing Chen; Yuji Morita; M Nazmul Huda; Teruo Kuroda; Tohru Mizushima; Tomofusa Tsuchiya
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

4.  The multidrug efflux protein NorM is a prototype of a new family of transporters.

Authors:  M H Brown; I T Paulsen; R A Skurray
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501

Review 5.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

6.  Imipenem resistance among Acinetobacter baumannii: association with reduced expression of a 33-36 kDa outer membrane protein.

Authors:  R B Clark
Journal:  J Antimicrob Chemother       Date:  1996-08       Impact factor: 5.790

7.  Molecular characterization of metallo-beta-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla(VIM-2) gene cassettes.

Authors:  Jong Hwa Yum; Keonsoo Yi; Hyukmin Lee; Dongeun Yong; Kyungwon Lee; June Myung Kim; Gian Maria Rossolini; Yunsop Chong
Journal:  J Antimicrob Chemother       Date:  2002-05       Impact factor: 5.790

8.  Molecular epidemiology of aminoglycoside resistance in Acinetobacter spp.

Authors:  R J Seward; T Lambert; K J Towner
Journal:  J Med Microbiol       Date:  1998-05       Impact factor: 2.472

9.  Evidence for chloramphenicol/H+ antiport in Cmr (MdfA) system of Escherichia coli and properties of the antiporter.

Authors:  T Mine; Y Morita; A Kataoka; T Mizushima; T Tsuchiya
Journal:  J Biochem       Date:  1998-07       Impact factor: 3.387

10.  NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli.

Authors:  Y Morita; K Kodama; S Shiota; T Mine; A Kataoka; T Mizushima; T Tsuchiya
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

View more
  62 in total

Review 1.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

Review 2.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

Review 3.  Xenobiotic efflux in bacteria and fungi: a genomics update.

Authors:  Ravi D Barabote; Jose Thekkiniath; Richard E Strauss; Govindsamy Vediyappan; Joe A Fralick; Michael J San Francisco
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  2011

4.  Sequence and structural determinants of ligand-dependent alternating access of a MATE transporter.

Authors:  Kevin L Jagessar; Derek P Claxton; Richard A Stein; Hassane S Mchaourab
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-19       Impact factor: 11.205

5.  The N-terminal domain of an archaeal multidrug and toxin extrusion (MATE) transporter mediates proton coupling required for prokaryotic drug resistance.

Authors:  Kevin L Jagessar; Hassane S Mchaourab; Derek P Claxton
Journal:  J Biol Chem       Date:  2019-07-09       Impact factor: 5.157

6.  Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.

Authors:  Sébastien Coyne; Ghislaine Guigon; Patrice Courvalin; Bruno Périchon
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

Review 7.  Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance.

Authors:  Lucía Fernández; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  Potent in vitro antibacterial activity of DS-8587, a novel broad-spectrum quinolone, against Acinetobacter baumannii.

Authors:  Saito Higuchi; Yoshikuni Onodera; Megumi Chiba; Kazuki Hoshino; Naomasa Gotoh
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

9.  Functional Characterization of AbaQ, a Novel Efflux Pump Mediating Quinolone Resistance in Acinetobacter baumannii.

Authors:  María Pérez-Varela; Jordi Corral; Jesús Aranda; Jordi Barbé
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

10.  Optimization of 4-Substituted Benzenesulfonamide Scaffold To Reverse Acinetobacter baumannii Serum-Adaptive Efflux Associated Antibiotic Tolerance.

Authors:  Michaelle Chojnacki; Xufeng Cao; Mikaeel Young; Rebecca N Fritz; Paul M Dunman; Daniel P Flaherty
Journal:  ChemMedChem       Date:  2020-08-13       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.